AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272200800028CXOMA (US) LLC
Overview
Award facts
- Net obligations
- $61.97M
- $61,966,783of $61.97M potential value
- Period of performance
- Nov 23, 2016 to Sep 14, 2014
- Ended
- Modifications
- 10
- Latest action Nov 23, 2016
- Contract type
- Definitive contract
- PIID HHSN272200800028C
Description of requirement
DEVELOP A SAFE HUMAN COMPATIBLE MAB-BASED FDP THAT NEUTRALIZES THE MAJOR SEROTYPES OF BONTA/B/E
Dates and value
- Award date
- Signed on Sep 5, 2008
- Potential end of performance
- Sep 13, 2014
- Current value
- $61,966,783Base and exercised options
- Potential value (if all options are exercised)
- $61,966,783
Obligations by fiscal year of action
- FY2017: -$2,868,504 (de-obligation)
- FY2012: $15,013,143
- FY2011: $12,082,342
- FY2010: $17,823,573
- FY2008: $19,916,229
Total across 5 fiscal years: $61,966,783
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 23, 2016. View on USAspending · Recipient on SAM.gov
Recipient
NameXOMA (US) LLC
LocationBERKELEY, CA
UEIH1AZAKRD1WM5
Business sizeSmall businessSize at award, per the contracting officer
Parent companyXOMA (US) LLC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
- Place of performance
- Berkeley, Alameda County, California 94710-2743
- Congressional district (place of performance)
- CA-12As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Only one source - otherONE
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- NIHNIAIDDMID0821(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Production of monoclonal antibody based therapuetics for botulism
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 5, 2008Base obligation at award: $19,916,229
- Latest action
- Nov 23, 2016 — Other administrative actionModification 10; obligation change -$2,868,504; administrative: no change in scope or value
- Latest substantive action
- Jul 27, 2012 — Option exercisedModification 6; obligation change +$5,058,975
- Latest funding action
- Mar 15, 2011 — Funding onlyModification 4; obligation change +$12,082,342; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action4
- Supplemental agreement (within scope)2
- Option exercised2
- Funding only1
- Vendor identifier change (novation)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$2,868,504
- Latest action: change in base and all options
- -$2,868,504
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 11
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930